Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review

por Tao, Chang-Juan, Lin, Gang, Xu, Ya-Ping, Mao, Wei-Min
Publicado 2015

Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A System...

por Xu, Ya-Ping, Li, Bo, Xu, Xiao-Ling, Mao, Wei-Min
Publicado 2015

RRM1 *151A>T, RRM1 ‐756T>C, and RRM1 ‐585T>Gis associated with increased susceptibility of lung cancer in Chinese patients

por Xu, Xiao‐Ling, Zheng, Ji, Mao, Wei‐Min, Ling, Zhi‐Qiang
Publicado 2016

The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience

por Xu, Xiao-Ling, Zheng, Wei-Hui, Zhu, Shuang-Mei, Zhao, An, Mao, Wei-Min
Publicado 2015

A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma

por Xu, Xiao-Ling, Yu, Hui-Qin, Hu, Wei, Song, Qian, Mao, Wei-Min
Publicado 2015

Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung ca...

por Xu, Xiao-Ling, Dan, Li, Chen, Wei, Zhu, Shuang-Mei, Mao, Wei-Min
Publicado 2016

Adjuvant chemotherapy plus radiotherapy is superior to chemotherapy following surgical treatment of stage IIIA N2 non-small-cell lung cancer

por Lei, Tao, Xu, Xiao-Ling, Chen, Wei, Xu, Ya-Ping, Mao, Wei-Min
Publicado 2016

The Molecular Mechanisms of Tanshinone IIA on the Apoptosis and Arrest of Human Esophageal Carcinoma Cells

por Wang, Jiang-Feng, Feng, Jian-Guo, Han, Jing, Zhang, Bei-Bei, Mao, Wei-Min
Publicado 2014

Autophagy Inhibition Stimulates Apoptosis in Oesophageal Squamous Cell Carcinoma Treated with Fasudil

por Xie, Fa-Jun, Zheng, Qiu-Qing, Qin, Jing, Zhang, Ling-Ling, Han, Na, Mao, Wei-Min
Publicado 2018

The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis

por Xie, Fa-Jun, Lu, Hong-Yang, Zheng, Qiu-Qing, Qin, Jing, Gao, Yun, Zhang, Yi-Ping, Hu, Xun, Mao, Wei-Min
Publicado 2016

Concurrent Chemoradiotherapy With or Without Induction Chemotherapy for Patients with Stage II Nasopharyngeal Carcinoma: An Update

por Jin, Ting, Zhang, Qun, Luo, Dong-Hua, Jiang, Feng, Jin, Qi-Feng, Chen, Yuan-Yuan, Chen, Xiao-Zhong, Mao, Wei-Min
Publicado 2019

Validation study of susceptibility loci for esophageal squamous cell carcinoma identified by GWAS in a Han Chinese subgroup from Eastern China

por Wang, Kai-Lai, Chen, Xiang-Liu, Lei, Lan, Li, Pei, Hong, Lian-Lian, Huang, Xian-Chong, Mao, Wei-Min, Mukaisho, Kenichi, Ling, Zhi-Qiang
Publicado 2019

Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma

por Yu, Xin-Min, Wu, Yi-Chen, Liu, Xiang, Huang, Xian-Cong, Hou, Xiu-Xiu, Wang, Jiu-Li, Cheng, Xiang-Liu, Mao, Wei-Min, Ling, Zhi-Qiang
Publicado 2016

Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma

por WANG, ZHUN, HAN, QIAN-BO, GU, JIA-LEI, YU, XIN-MIN, SUN, XIAO-JIANG, LIN, QING-REN, FANG, JUN, WANG, YUE-ZHEN, XU, YA-PING, MAO, WEI-MIN
Publicado 2015

Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG...

por Zhong, Wen-Zhao, Yan, Hong-Hong, Chen, Ke-Neng, Chen, Chun, Gu, Chun-Dong, Wang, Jun, Yang, Xue-Ning, Mao, Wei-Min, Wang, Qun, Qiao, Gui-Bin, Cheng, Ying, Xu, Lin, Wang, Chang-Li, Chen, Ming-Wei, Kang, Xiao-Zheng, Yan, Wan-Pu, Liao, Ri-Qiang, Yang, Jin-Ji, Zhang, Xu-Chao, Liu, Si-Yang, Zhou, Qing, Wu, Yi-Long
Publicado 2023

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

por Zhong, Wen-Zhao, Wang, Qun, Mao, Wei-Min, Xu, Song-Tao, Wu, Lin, Wei, Yu-Cheng, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Yin, Rong, Yang, Fan, Ren, Sheng-Xiang, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Yang, Jin-Ji, Yan, Hong-Hong, Yang, Xue-Ning, Liu, Si-Yang, Zhou, Qing, Wu, Yi-Long
Publicado 2021

Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinica...

por Mao, You-Sheng, Gao, Shu-Geng, Li, Yin, Hao, An-Lin, Liu, Jun-Feng, Li, Xiao-Fei, Rong, Tie-Hua, Fu, Jian-Hua, Ma, Jian-Qun, Xu, Mei-Qing, Zhang, Ren-Quan, Xiao, Gao-Ming, Fu, Xiang-Ning, Chen, Ke-Neng, Mao, Wei-Min, Liu, Yong-Yu, Liu, Hong-Xu, Zhang, Zhi-Rong, Fang, Yan, Fu, Dong-Hong, Wei, Xu-Dong, Yuan, Li-Gong, Muhammad, Shan, Wei, Wen-Qiang, Chiu, Philip Wai-Yan, Lloyd, Shane, Schlottmann, Francisco, Meredith, Kenneth, Pimiento, Jose M., Gao, Yi-Bo, He, Jie
Publicado 2022

Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes

por Liu, Si-Yang, Bao, Hua, Wang, Qun, Mao, Wei-Min, Chen, Yedan, Tong, Xiaoling, Xu, Song-Tao, Wu, Lin, Wei, Yu-Cheng, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Yin, Rong, Yang, Fan, Ren, Sheng-Xiang, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Yan, Hong-Hong, Dong, Song, Zhang, Xu-Chao, Su, Jian, Yang, Jin-Ji, Yang, Xue-Ning, Zhou, Qing, Wu, Xue, Shao, Yang, Zhong, Wen-Zhao, Wu, Yi-Long
Publicado 2021

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel

por Wu, Yi-Long, Wang, Chang-Li, Sun, Yan, Liao, Mei-Lin, Guan, Zhong-Zhen, Yang, Zhi-Min, Zhou, Qing-Hua, Lu, Shun, Cheng, Ying, Liu, Xiao-Qing, Zhang, Xu-Chao, Zhou, Caicun, Wang, Jie, Zhou, Qing, Song, Yong, Han, Bao-Hui, Ma, Zhi-Yong, Yang, Fan, Wang, Qun, Chuai, Shao-Kun, Shao, Yang, He, Wei, Zhu, Guanshan, Xiong, Lei, Wang, Jian-Jun, Chen, Ke-Neng, Zhang, Li, Mao, Wei-Min, Ma, Sheng-Lin, Feng, Ji-Feng, Yang, Xue-Ning, Xu, Lin, Chen, Gang, Zhao, Jian, Song, Qi-Bin, SHEN-TU, Yang, Qiao, Gui-Bin, Yu, Ding, Yu, Shi-Ying, Hu, Yi, Chen, Ming, Chen, Gong-Yan, Fan, Yun, Zhang, He-Long, Liang, Jun, Zhu, Guang-Ying, Cui, Jiu-Wei, Yang, Jin-Ji, Zhao, Qiong, Zhao, Ming-Fang, Lu, You, Chang, Jian-Hua, Li, Jun-Ling, Yang, Yue, Hu, Jie, Gu, Chun-Dong, Zhang, Yi-Chen, Zhong, Wen-Zhao
Publicado 2017